DOCTOR STRANGE #74

Cover shows strong, bright color with no visible fading; corners appear sharp with only minor softness at the top right; no creases, tears, or spine stress lines are visible in this image. The book is in a protective sleeve which adds some glare but the surface underneath looks clean and glossy. Interior pages and back cover were not assessed, so the grade reflects only the visible front cover.

Doctor Strange #74 arrived in December 1985 as part of the extended Peter Gillis run that carried the Sorcerer Supreme's second ongoing series through its final years before cancellation at #81. Gillis's tenure reshaped Stephen Strange's supporting cast and mystical rules-set in ways later writers would build on, but this particular issue is a mid-run chapter rather than a springboard for any new character, villain, or status-quo shift that collectors specifically chase. It reflects the workmanlike, competently plotted mysticism-and-melodrama formula that defined the title in its later Copper Age stretch.

Market data for the issue is thin, consistent with a common direct-market book from a period of low print runs and limited ongoing collector demand outside completists of the Doctor Strange title. Certified population is modest, with the overwhelming majority of graded copies clustered at 9.8, and sales activity is sparse across all other grades, indicating that most surviving copies were preserved in high grade from the outset rather than pulled from heavily circulated reading copies. Pricing across the grade curve is flat and unremarkable, with no premium tier or crossover appeal driving demand.

This is a book for series completists and Doctor Strange run-builders rather than speculative investors. Raw copies in lower grades trade for pocket change and rarely surface as individual sale listings, while mid-grade raw copies move modestly within long-box and bulk-lot contexts. Only pristine 9.8 slabs command any meaningful premium, and even that ceiling remains low relative to Bronze and Silver Age Doctor Strange material; buyers seeking this issue are typically filling a specific gap in a Volume 2 run rather than pursuing it as a standalone investment.